CD36 and coronary artery disorder: CD36 protein levels were also decreased in Mφ treated with CAD-PF-sEV when compared with all other groups (P < 0.04 vs non-CAD PF-sEV; P < 0.0001 vs PBS and untouched) (Figure 6C).